Mouse polyoma virus-like particles (or pseudocapsids) are composed solely of recombinant viral coat protein. They can interact with DNA and transport it to cells, resulting in gene expression both in tissue culture and in mice. We demonstrate that DNA transfer in vitro depends on partial packaging of DNA within the virus-like capsid. Cell surface sialic acid residues and an intact microtubule network, required for viral infectivity, are also necessary for pseudocapsidmediated gene expression from heterologous DNA. Thus, gene delivery in this system requires pathways utilised by polyoma virions, rather than proceeding via the 'nonspecific' endosomal route typical of nonviral systems such as lipo-
Introduction
Gene therapy is being explored as treatment for human diseases and a number of clinical studies have successfully demonstrated proof of principle. 1 Viral vectors have been widely used in such studies as they are able to deliver genes efficiently and achieve long-term expression. However, viral vectors have the potential for introducing or generating infectious viruses and the immune system rapidly clears modified cells expressing virally encoded gene products. These factors, in conjunction with problems of large-scale production, have driven a search for alternative nonviral delivery systems.
One approach being developed uses virus-like particles (VLPs) to deliver genes. VLPs are composed of recombinant structural viral coat proteins, which spontaneously assemble into protein spheres closely resembling the parental virus particle. 2 Unlike viruses they are composed only of one protein species and are devoid of nucleic acid. Such structures were originally described for mouse polyoma virus coat protein, VP1, [3] [4] [5] and it has been shown that a number of different viral coat proteins can behave in a similar manner. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] VLPs retain their ability to package DNA. Particles composed of the coat protein packaged with heterologous DNA have been isolated from cells in which the recombinant protein is syn- somes or calcium phosphate precipitates. Despite the fact that all cells appear to internalise pseudocapsid/DNA complexes, only a proportion show productive gene delivery. Bulk internalisation of complexes is dependent on actin fibres, but not cell surface sialic acid or microtubules, indicating that a second transport pathway exists for pseudocapsids which is nonproductive for gene transfer. The model suggested by these data demonstrates the virus-like properties of the pseudocapsid system, and provides a basis for further development to produce a highly effective gene delivery vehicle. Gene Therapy (2000) 7, 2122-2131.
thesised and partial packaging of plasmid DNA has also been observed on mixing the purified components in vitro. 9, 18, 19 Furthermore, VLPs composed of mouse polyoma virus VP1 (called pseudocapsids) can transfer plasmid DNA to cells, resulting in heterologous gene expression both in vitro and in vivo. [20] [21] [22] DNA transfer in vitro has also been reported for a number of other VLPs, including those derived from human polyoma and papilloma viruses. 15, 16, 23 Thus, VLPs have the potential to be developed into a new family of gene therapy vectors with different delivery characteristics and host ranges, dependent on the nature of the parental virus.
In vivo it has been observed that genes introduced with pseudocapsids are initially expressed at a low level, but that expression is prolonged and may even increase with time. 21, 22 Furthermore, in vitro expression is sustained even though initiating from relatively few copies of DNA compared with transfection with calcium phosphate precipitates. 20, 21 This pattern of expression is not typical of gene transfer by nonviral methods, where high levels of gene product are detected, but expression is transient. 24 The quantity of pseudocapsid/DNA complex required to achieve expression is, however, similar to that for calcium phosphate-mediated transfer, with respect to the number of DNA molecules used. Thus, pseudocapsid/DNA complexes are considerably less active than the corresponding virus particles.
To provide insight into why pseudocapsid-mediated DNA delivery appears to favour long-term expression, and to identify ways of improving DNA transfer efficiency, the interaction of pseudocapsid/DNA complexes with cells was studied. Pseudocapsids were found to be taken up into cells by at least two pathways. The first route resulted in gene expression and depended on cell surface sialic acid residues and intracellular microtubules, being sensitive to treatment of the cells with neuraminidase and nocodazole. The second route, accounting for the bulk of the material, was cytochalasin D sensitive and, therefore, actin fibre dependent, but did not lead to productive transfer of DNA to cells. Thus, a relatively minor population of pseudocapsid/DNA complexes which enter the cell appear to transfer DNA to the nucleus in a specific virus-like manner, which may result in delivery of DNA favouring long-term gene expression.
Results
Partial packaging of pseudocapsids with DNA is required for gene transfer Nonviral gene transfer agents, such as cationic polymers or liposomes, form aggregates with DNA that are taken up nonspecifically by cells. 25 These aggregates are composed of relatively disordered complexes stabilised by ionic interactions between the carrier and the DNA phosphate backbone. In contrast, pseudocapsids and empty capsids from a natural polyoma virus infection appear to interact with DNA by partially packaging it. 19, 26 We therefore investigated whether pseudocapsid-mediated gene transfer depends on a specific packaging reaction.
It has been demonstrated that empty capsids package DNA most efficiently when complexes are formed at a molar ratio of 5:1 capsids:DNA. 26 To determine whether the degree of packaging influences the efficiency of gene transfer, pseudocapsid/DNA complexes were prepared at different molar ratios and the resulting complexes assayed for gene transfer activity. Pseudocapsids were incubated with a plasmid encoding the enhanced green fluorescent protein (EGFP) gene and the mixtures applied to monkey epithelial cos 7 cells in a transient expression assay (see Materials and methods). The percentage of cells expressing EGFP for each mixture, counted by fluorescence microscopy, is shown in Figure 1A . As with empty viral capsids, the highest transfer activity was obtained at the optimal molar packaging ratio of 5:1 (15 g pseudocapsids mixed with 0.5 g DNA), either side of which DNA transfer activity was lower, demonstrating a correlation between packaging and DNA transfer.
To test this relationship further, the DNA transfer activity of 'heavy pseudocapsids' was assayed. 'Heavy pseudocapsids' are also derived from VP1 recombinant baculovirus-infected insect cells, but already have heterologous DNA packaged inside them. 18 These particles do not interact with exogenously added DNA in gel shift assays and when observed by electron microscopy ( Figure 1B , panel a) they do not form stable interactions with plasmid DNA, in contrast to 'empty pseudocapsids' (panel b; plasmid DNA alone is shown in panel c). 19 Heavy pseudocapsids exhibited little or no DNA transfer activity when mixed with EGFP DNA and tested in the cos cell assay, in contrast to empty pseudocapsids, which gave more than a 10-fold increase in gene transfer efficiency compared with DNA alone ( Figure 1C ). These results confirm that a specific packaging reaction is required to form complexes of pseudocapsids and DNA capable of mediating DNA transfer. Gene transfer is enhanced on association of pseudocapsid/DNA complexes into larger aggregates The results indicate that specific packaging is necessary for efficient gene transfer of exogenous DNA by pseudocapsids. However, a significant portion of DNA associated with pseudocapsids appeared not to be packaged when observed by EM ( Figure 1B, panel b) , raising the question of how the DNA is protected from nucleases during gene transfer. Furthermore, although the optimal molar ratio was 5:1, on average only two to four pseudocapsids could be seen on each DNA molecule. One possible explanation for these observations is that the remaining capsids interact with the DNA at a lower affinity, but are displaced by the spreading forces used to prepare samples for EM. 19 Evidence to support this hypothesis was provided by examining the complexes using atomic force microscopy (AFM). Sample preparation for this method is less disruptive than for EM, as the samples are allowed to adsorb on to the hydrophobic surface of a mica sheet and then gently dried. Pseudocapsids or DNA alone observed by AFM distributed evenly across the mica surface (Figure 2a and b) . Pseudocapsid/DNA complexes formed at a molar ratio of 0.08:1 resulted in structures similar to those observed by EM (Figure 2c ), in that the DNA was partially unwound and associated with occasional spherical pseudocapsid-like structures (indicated by an arrow). However, when the ratio of pseudocapsids to DNA was increased, the majority of the material associated into larger particles, with dimensions of up to a micrometre. Figure 2 , panels d and e show 10 m and 1 m scans of this sample, demonstrating association of pseudocapsid/DNA complexes both at low and high resolution. Some smaller structures were also observed in these samples (for example, Figure 2f ; 0.25 m scan), with several pseudocapsids per DNA molecule. Thus, it appeared that in solution the majority of pseudocapsid/DNA complexes form much larger, loosely associated structures, in which many molecules of DNA and pseudocapsids aggregate together.
To determine whether the smaller complexes and larger aggregates observed by AFM were capable of DNA transfer, pseudocapsids and DNA mixed at a molar ratio of 5:1 were fractionated on a 10-40% sucrose gradient. Ten fractions were collected and tested for both DNA transfer activity and VP1 content. The highest gene transfer activity was associated with the heavier fractions ( Figure 3 , fractions 1-3) and peaked in fraction 2. Considerable activity was also associated with fraction 10. This fraction, being the last collected, also contained insoluble matter from the bottom of the gradient. However, more VP1 was detected by Western blotting in the central fractions of the gradient (fractions 4-6) with refractive indices of 1.36-1.37, corresponding to the migration position of free pseudocapsids in gradients run under similar conditions. 21, 27, 28 Thus, more DNA transfer activity was associated with VP1 derived from the heavier fractions than the lighter small aggregates.
These results suggest a model for pseudocapsid-DNA interaction. Initially, a packaging reaction takes place, which is of high enough affinity to withstand the spreading forces in EM. Then in the presence of additional pseudocapsids or aggregation, complexes better able to productively transfer DNA into cells are formed. As gene transfer is reduced if pseudocapsids are mixed at molar ratios greater than 5:1, the greater excess of pseudocapsids may drive the complexes into even larger aggregates which the cells are unable to take up efficiently.
Pseudocapsids enter cells by two routes, only one of which is productive for gene transfer Pseudocapsids are endocytosed by cells and transported in a cytoskeleton-dependent manner: Although a packaging step is required for DNA transfer, large loosely associated complexes of pseudocapsids and DNA appear to be most efficient at mediating gene expression. To understand how these complexes transfer DNA to cell nuclei, early stages of cell entry and uptake of pseudocapsids were characterised by immunofluorescence. Initially, binding and entry of pseudocapsid/DNA complexes into cells was examined as a function of time. The assay was performed in both mouse 3T6 fibroblasts ( Figure 4 , panels a-c) which support polyoma virus replication, and cos 7 cells (panels d-f) which were used for the DNA transfer assays. Pseudocapsid/DNA complexes were allowed to adsorb on to the surface of cells at 0°C, cultures were shifted to 37°C and uptake observed after 0, 30 min and 3 h by indirect immunofluorescence with an antibody raised against VP1 (panels a and d, b and e, and c and f, respectively). Pseudocapsids were endocytosed and transported within the cell, reaching steady state by 2-4 h. In 3T6 cells, most VP1-specific fluorescence was found near the nucleus, whereas in cos 7 cells it was seen both near the nucleus and at the cell periphery. Panels g and h (Figure 4) show images of pseudocapsid-derived material in a single 3T6 or cos 7 cell after a 3 h incubation at 37°C, captured as a series of planes through the Z axis of the cell and reconstructed in three dimensions (see Materials and methods). The cells were also stained with Texas red-conjugated phalloidin to visualise actin fibres. Two different XZ sections (panels g 1 and 2 , and h 1 and 2 ) were taken through each cell, at positions indicated by the blue lines in panels g and h, of 0.134 m width. These sections demonstrate that much of the VP1 immmunoreactive material (green fluorescence) is located very close to the actin fibres (red fluorescence) and shows that a significant proportion of pseudocapsids in each case have migrated into the cell cytoplasm. Furthermore, a similar localisation was observed with polyoma virion particles (data not shown). Uptake to this internal location could not be explained by membrane recycling, as labelling plasma membranes with the lipophilic carbocyanin, DiIC 16 (3) , resulted in accumulation of the dye into cellular locations that differed from those seen for pseudocapsids (data not shown). Very little colocalisation was observed in double labelling experiments with antibodies raised against cathepsin B (Figure 4i ), indicating that the compartment occupied by pseudocapsids was not predominantly lysosomal. Also, VP1 did not colocalise with the microtubule organising centre and is, therefore, unlikely to be associated with Golgi bodies. The closely related virus, SV40, has been shown to accumulate at the endoplasmic reticulum following cell entry. 29 However, the asymmetric staining pattern observed for pseudocapsids is not typical for this structure. Thus, the identity of the sites to which pseudocapsid/DNA complexes migrate remains unresolved.
Pseudocapsid-mediated DNA transfer requires cell surface sialic acid residues: Viral infection of cells depends upon binding to a sialic acid component of the viral receptor. 30 To test whether sialic acid binding is necessary for pseudocapsid uptake, DNA transfer was carried out in the presence of neuraminidase, which cleaves sialic acid residues from the surface of cells and blocks virus binding and infection. 31 As shown in Figure 5A (filled bars), this treatment resulted in a complete block of both virus and pseudocapsid-mediated gene transfer, as measured by EGFP expression for pseudocapsids and early antigen (large-T) expression for the virus. However, neuraminidase treatment of the cells did not affect calcium phosphate transfection of the EGFP gene. Thus, pseudocapsids retain the need for binding to sialic acid to mediate DNA transfer.
The effect of neuraminidase on uptake of pseudocapsids, as measured by immunofluorescence, was also tested. 3T6 or cos 7 cells were treated with neuraminidase and pseudocapsid uptake observed by immunofluorescence ( Figure 5B, panels a-d and e-h, respectively) . SurGene Therapy prisingly, removal of cell surface sialic acid residues had no discernible effect on either the binding of pseudocapsids at 0°C to the surface of either type of cell (compare panels a and c, or e and g, for 3T6 or cos 7 cells, respectively), or their migration into the cell (panels b and d, or f and h). This suggests that uptake of the bulk of pseudocapsids in this system is not receptor mediated, nor does it result in productive DNA transfer. Thus gene transfer resulting in gene expression appears to be exclusively sialic acid/receptor dependent. Further evidence for a specific route of delivery is given below.
Intracellular transport of pseudocapsids requires the cytoskeleton: Occasionally, VP1-specific fluorescence was observed in filamentous patterns in cells (examples are indicated with arrows in Figure 4c ). Intracellular transport of a number of viruses depends on cytoskeletal elements. [32] [33] [34] To investigate whether this may also be the case for pseudocapsids, cells were incubated with pseudocapsid/DNA complexes, fixed after 3 h, and costained for either microtubules, or actin filaments, and pseudocapsids. Some colocalisation of pseudocapsids was observed with both cytoskeletal structures. A network of microtubules can be seen in cos 7 cells in Figure  6A (panel a, red fluorescence) with pseudocapsids (green fluorescence) in aggregates near the nucleus. 3T6 cell microtubules were unstable in this assay, possibly due to the adsorption step that was carried out at 0°C. A similar pattern would have probably been observed, however, given the localisation of pseudocapsids in these cells, as seen in Figures 4 and 5 and Figure 6A , panel c. More prominent colocalisation appeared to exist with actin fibres. In 3T6 cells (panel c) pseudocapsid complexes often appeared to be sited directly on the phalloidin
Figure 3 Fractionation of pseudocapsid/DNA complexes by sucrose density gradient centrifugation. Pseudocapsid/EGFP DNA complexes, formed at a molar ratio of 5:1, overlayed on to a 10-40% sucrose gradient and centrifuged for 1 h. Collected fractions (two-fifths of each) were added to cos 7 cells and cells expressing EGFP counted by fluorescence microscopy, 24 h later (bars). Inset: one hundredth of each fraction was run on 12% SDS-PAGE, electroblotted on to Immobilon P membrane (Millipore) and probed with an anti-VP1 monoclonal antibody. 5 Immune complexes were visualised with an HRP-conjugated secondary antibody and chemiluminescent ECL reagent (Amersham). Only the portion of the gel containing VP1 is shown.
stained fibres, whereas in cos 7 cells, where the fibres were less well formed, colocalisation was less obvious.
As both capsids and cytoskeleton components were abundant in the cells, it is possible that a certain amount of overlapping signal could be coincidental. To test this, cells were treated with nocodazole (cos 7 cells) or cytochalasin D (3T6 cells) that depolymerise microtubules and actin filaments, respectively. Figure 6A (panels b and d) show the results of pretreatment of cells with these reagents, followed by incubation with pseudocapsid/ DNA complexes for 3 h. Cytochalasin D (panel d) appeared to have the greater effect, virtually abolishing localisation of pseudocapsids to the site near the nucleus. A pattern of phalloidin stained material similar to that found in cos 7 cells was observed, with lightly stained indistinct fibres and globular phalloidin stained material. Also, capsid distribution was more reminiscent of that found in cos 7 cells. Taken together, these data suggest that the state of the actin fibre network has a significant influence on pseudocapsid localisation in this assay.
To test the relevance of this observation to DNA transfer leading to gene expression, cells were incubated in the presence of nocodazole or cytochalasin D and then treated either with pseudocapsid/DNA complexes, infected with wild-type polyoma virus, or transfected with DNA/calcium phosphate precipitate. Under the conditions used here, neither reagent reduced calcium phosphate transfection efficiency ( Figure 6B , right-hand panel). Nocodazole actually appeared to result in an increase in transfection, possibly due to mitosis being retarded in the cells, increasing the chances of DNA entering the nucleus during nuclear envelope breakdown. In contrast, DNA transfer by both pseudocapsids and virus (left and central panels) was almost completely abolished by treatment with nocodazole, but not by cytochalasin D. Thus, pseudocapsids and virus require intact microtubules and not actin fibres to mediate gene transfer. These data support the notion that pseudocapsids enter cells and deliver DNA by a regulated mechanism, similar to viral entry. Furthermore, consistent with the experiments using neuraminidase, they show that there are two routes of uptake of pseudocapsids in cells. One of these is sialic acid and microtubule dependent and results in gene transfer, whereas the other is actin fibre dependent and is not involved in gene transfer.
Discussion
The major coat proteins of several papovaviruses have the ability to self-assemble into spherical particles with morphologies similar to those of the parental virus. We and others have demonstrated that these particles can interact with cells and carry heterologous DNA into them in a manner that results in gene expression. 15, 16, 20, 21, 23 In this article, we demonstrate that the mechanism of DNA transfer by polyoma pseudocapsids exhibits many characteristics in common with virus infection, rather than delivering DNA by nonspecific routes typical of nonviral systems. We propose that VP1 is sufficient for DNA binding and transfer of the pseudocapsid/DNA complexes to the nucleus via a receptor-mediated route, resulting in efficient gene expression. Thus, pseudocapsids retain many of the advantages of a viral vector, and provide a useful class of delivery systems for gene transfer in vivo.
Pseudocapsid-mediated gene transfer depends on a physical interaction of DNA with 'empty' pseudocapsids, involving partial packaging of the DNA. It is, like virus infection, almost completely blocked by treatment of the cells with neuraminidase, indicating that DNA transfer by pseudocapsids is exclusively receptor mediated and does not occur by passive, or nonspecific uptake. Subsequent steps in the passage of the complexes to the nucleus also occur in a virus-like manner, since both virus and pseudocapsids require intact microtubules, but not actin fibres, to deliver their DNA to the nucleus for expression. Whether this transport is regulated by information encoded in VP1, or determined by the initial binding event, is not known. Microtubules regulate many events concerned with transport of vesicles in cells. Recent data have highlighted their role in movement of endocytic vesicles in both retrograde and anterograde directions and a number of viruses travel towards the nucleus along microtubule structures. [33] [34] [35] [36] Polyoma virus and pseudocapsid/DNA complexes may, therefore, use a similar mechanism to deliver DNA to the nucleus. Alternatively, the cell surface accessibility of the receptor for pseudocapsids may be microtubule dependent, as has been described previously. 37 Since the receptor for mouse polyoma virus has yet to be identified this cannot be 1 and g 2 and h 1 and h 2 , respectively) . The pixels on the Z axis of panels g 1 , g 2 , h 1 ruled out, but it would still be consistent with receptormediated uptake.
1% Triton X 100 and pseudocapsid uptake followed in cells by immunofluorescence with anti-VP1 monoclonal antibody and Oregon green-conjugated secondary antibody (Molecular Probes). 5 Cell nuclei were counterstained (blue) with DAPI. Arrows in c indicate examples of VP1 containing complexes apparently aligning on filamentous structures within the cell. Panels d-f: VP1 immunoreactive material localised in cos 7 cells treated as above and fixed at: (d) 0 h; (e) 30 min; (f) 3 h. Panels g and h: a single 3T6 cell (g), or cos 7 cell (h), treated as above and harvested at 3 h, immunostained for VP1 (green), and stained for actin fibres with Texas red-conjugated phalloidin (Molecular Probes) (red). Stacks of images were taken through each cell at 0.3 m intervals, reconstructed (as described in Materials and methods) and XZ orthogonal planes of 0.134 m thickness were taken at two different places, as indicated by the blue lines in panels g and h (panels g
In common with the accepted model of polyoma virus uptake, pseudocapsid/DNA complexes have at least two modes of entry into the cell, one resulting in gene transfer and the other apparently nonproductive. 38 The majority of VP1 immunoreactive material was observed to migrate to an intracellular location near the nucleus, which was not lysosomal in nature. This movement was sensitive to cytochalasin D treatment and, given that a number of VP1 containing particles colocalised with actin fibres, may depend on regulated movement along the fibres themselves. This population of complexes, however, was apparently non-productive for DNA transfer since no reduction in gene expression was observed in the presence of cytochalasin D. It may be that this route represents a default pathway, for instance by phagocytosis, for material that did not follow the preferred viral route. In this regard, virus infection (and in one case pseudocapsid/DNA transfer) in cells was more efficient in the presence of cytochalasin D. One explanation for this observation could be that when the actin transport pathway was blocked, some particles were re-routed to the productive pathway.
It is not known why such a large proportion of VP1 adopts this actin-dependent route, although it may account for why pseudocapsids are much less effective at DNA transfer than virus. It is clear that pseudocapsids
Gene Therapy can associate into large aggregates in the presence of DNA, as, even in low ionic strength media, particles of micrometre dimensions could be observed. Such aggregates could reduce the effectiveness of transfer by sequestering material. However, as virtually all cells can be seen to have taken up VP1, it seems more likely that the size of the particle may impede specific receptor-mediated internalisation. Alternatively, differences in surface characteristics or conformation induced by abnormal packaging of plasmid DNA, or lack of the minor coat proteins, VP2 and 3, might affect interactions with receptors or transport proteins. In support of this notion, pseudocapsids made from VP1 and VP2 are more effective in blocking interaction of virus with the cell, than those composed of VP1 alone. 39 Thus, a particular function may be missing from pseudocapsids, which, if replaced, could restore the efficiency of transfer to levels nearer that achieved with viruses.
One of the major drawbacks in the field of gene therapy is the lack of a suitably safe and efficient vector that can confer long-term expression in target tissues. 1, 40, 41 The polyoma virus-like particle system has been shown to deliver DNA to cells and tissues in a way that results in prolonged gene expression. 20, 21 This property may be a consequence of the specific virus-like nature of uptake and transport of DNA to the nucleus, as reported here. The identification of two uptake pathways may provide at least a partial explanation for the current inefficiency Gene Therapy of pseudocapsids in DNA transport and provide a basis for optimising the system. Once the relatively low efficiency of DNA transfer is bettered, this new system should prove a promising candidate for future gene therapeutic applications.
Materials and methods
All chemicals were obtained from Sigma Chemical Co. or BDH Chemicals, Poole, UK. Secondary and conjugated antibodies (used at a 1/200 dilution, unless otherwise noted) were obtained from Dako (Ely, UK). Anti-cathepsin B antibody and FITC-conjugated secondary antibody were from Santa Cruz Biotechnology (Autogen Bioclear, Calne, UK).
Preparation of pseudocapsids and pseudocapsid/DNA complexes VP1 was expressed in Sf9 insect cells from a recombinant baculovirus. 5 Pseudocapsids were purified to near homogeneity by differential gradient centrifugation, from cells infected for 96 h, as previously described. 21 Pseudocapsid/DNA complexes were prepared by incubating purified pseudocapsids, diluted 10-fold with water, with CsCl purified supercoiled plasmid DNA at a molar ratio of 5:1, corresponding to a weight ratio of 30:1, for 15 min at room temperature, unless stated otherwise.
EGFP gene transfer assays
For pseudocapsid-mediated transfer, cells washed with Dulbecco's modified Eagle's medium (DMEM) lacking serum were incubated with pseudocapsid/DNA complexes in a small volume of DMEM for 90 min. Cultures were then washed and grown in DMEM supplemented with 5% FCS for 24 h. Cos 7 cells express SV40 LT and plasmid pEGFP (Clontech, Palo Alto, CA, USA) contains an SV40 origin of replication, resulting in amplification of DNA to facilitate detection of marker genes in transient cultures. 42 Calcium phosphate transfections and virus infections were carried out as previously described. 27, 43 Experiments were typically carried out on 2-3 × 10 5 cells plated on 13-mm diameter coverslips. Unless stated otherwise, 0.5 g DNA was used per coverslip and at the end of the incubation period coverslips were rinsed in PBS, inverted on to a slide and expressing cells counted by fluorescence microscopy using an FITC filter set. Electron microscopy and atomic force microscopy EM: Complexes of pseudocapsids and DNA, or DNA alone (50 g/ml with respect to DNA) were prepared for EM using a modified aqueous spreading technique, as described. 19 Gene Therapy AFM: Samples were diluted in water to 1 g/ml, dropped on to the surface of freshly cleaved mica, and allowed to adsorb for 2 min. The mica surface was then rinsed with water and the samples dried overnight under mild vacuum, in a desiccator. Silicon probe tips were used to scan the samples in tapping mode using a Multimode SPM and Nanoscope III control system (Digital Instruments, Santa Barbara, CA, USA).
Flow cytometry analysis Cos 7 cells, untreated, or treated with DNA or pseudocapsid/DNA mixtures, were harvested 48 h later by trypsinisation. Trypsin was inactivated by dilution in DMEM supplemented with 5% FCS, cells were washed, resuspended in PBS and sorted on a Becton Dickinson Vantage FACS (San Jose, CA, USA), using an argon laser at 488 nm wavelength. Fluorescent events were gated for forward and side scatter typical of live single cells. Ten thousand events were counted for each sample and positive cells defined as having a fluorescence level above the background autofluorescence peak. Data were analysed using CellQuest version 3.1F. A small percentage of highly fluorescent events was observed in the pseudocapsid/DNA mixture samples. These events distributed randomly throughout the bulk population of healthy cells confirming they were highly fluorescent cells.
Gradient analysis
Pseudocapsid/DNA complexes (600 g with respect to pseudocapsids), prepared as described above, were overlayed on to a pre-formed sucrose gradient (10-40% in 20 mm Tris, 150 mm NaCl, 0.01 mm CaCl 2 , pH 7.4) and sedimented by centrifugation at 100 000 g for 1 h. Fractions were collected and immediately applied to cells diluted in DMEM for DNA transfer assays.
Uptake assays and immunofluorescence Cos 7 or 3T6 cells (5 × 10 4 ) were grown on glass coverslips in 24-well dishes. For the uptake assays, cells were incubated in DMEM, containing 20 mm Hepes, pH 7, and 0.5% BSA, for 30 min at 37°C, followed by incubation with pseudocapsid/DNA complexes in ice-cold medium for 30 min on ice. Following several rinses with cold medium, cells were incubated in DMEM supplemented with 5% FCS for the appropriate time at 37°C. Harvesting was by fixing in 3.7% formaldehyde, 250 mm sucrose in PBS, for 15 min, and permeabilisation in 0.1% Triton X 100. Pseudocapsids were localised by incubating with a VP1-specific monoclonal antibody for 1 h. 5 Immune complexes were detected with either Oregon green-conjugated secondary anti-mouse Ig polyclonal antibody (Molecular Probes, Leiden, The Netherlands), or rabbit anti-mouse Ig polyclonal antibody and an RITC-conjugated swine anti-rabbit Ig antibody. Microtubules were detected with Cy3-conjugated anti ␤-tubulin (Sigma, Poole, UK), and actin fibres with Texas red-conjugated phalloidin (Molecular Probes), according to the manufacturer's instructions. Cathepsin B was localised using an anti-cathepsin B antibody, at a 1/20 dilution. Cells were mounted in Vectorshield containing DAPI (Vector Laboratories, Burlingame, CA, USA). Virus infection was assessed by scoring the number of cells expressing the early LT antigen after 24 h by immunofluorescence of fixed cells, using a monoclonal antibody to LT. Cells were visualised by fluorescence microscopy using FITC, RITC or DAPI filter sets and Plan-apochromat × 63 and × 100 lenses. Images were captured using the Digital Acquire function of the Metamorph Imaging program (Universal Imaging Systems, West Chester, PA, USA). Exposure times were typically 3 s for pseudocapsids, 1.5 s for microtubules and actin fibres and 35 ms for nuclei. Images were overlayed using the Colour Align function. Where a wide dynamic range of signals was obtained, stacks of section were taken 0.3 m apart and images were then deblurred and reconstructed using the Autodeblur and Metamorph programs. Images from different fluorophores were colour aligned and three-dimensional reconstructions performed. Reconstructed images are shown as viewed from the top (angle of 0°). XZ sections were taken using the Orthogonal Plane function, and images of a single pixel (0.134 m) thickness shown.
